Synergistic antibacterial and antibiofilm activity of silver nanoparticles biosynthesized by lignin-degrading fungus

Abstract

Background

The fabrication of silver nanoparticles (Ag-NPs) through green chemistry is an emerging area in the field of medical nanotechnology. Ag-NPs were fabricated by enzymatic reduction of AgNO₃ using two lignin-degrading fungus Aspergillus flavus (AfAg-NPs) and Emericella nidulans (EnAg-NPs). The prepared Ag-NPs were characterized by different spectroscopic techniques. Antibacterial activity of prepared Ag-NPs was demonstrated against selected Gram negative (Escherichia coli and Pseudomonas aeruginosa) and Gram positive (Staphylococcus aureus) bacteria in the term of minimum bactericidal concentration (MBC) and susceptibility constant (Z). The synergistic antibacterial activity of Ag-NPs with four conventional antibiotics was also determined by the fractional inhibitory concentration index (FICI) using the checkerboard microdilution method. The antibiofilm potential of Ag-NPs was also tested.

Results

The plasmon surface resonance of biosynthesized Ag-NPs shows its characteristic peaks at UV and visible region (~450 and 280 nm). Fourier transform infrared spectrometer (FTIR) analysis confirms the nature of the capping agents as protein (enzyme) and indicates the role of protein (enzyme) in reduction of silver ions. The average particle size and charge of synthesized Ag-NPs was ~100 nm and ~−20 mV, respectively. X-ray diffraction (XRD) and TEM analysis confirmed the purity, shape, and size (quasi-spherical, hexagonal, and triangular) of Ag-NPs. Energy-dispersive X-ray spectroscopy (EDX) data validate the biological synthesis of Ag-NPs. Low MBC and high susceptibility constant indicate the high antimicrobial strength of biosynthesized Ag-NPs. The antibacterial analysis demonstrates the synergistic antimicrobial activity of Ag-NPs with antibiotics. This study also shows that biosynthesized Ag-NPs have ability to inhibit the biofilm formation by 80–90 %.

Conclusion

The Aspergillus flavus and Emericella nidulans-mediated biosynthesized Ag-NPs have significant antimicrobial activity and demonstrate synergistic effect in combination with antibiotics. It suggests that nanoparticles can be effectively used in combination with antibiotics to improve the efficacy of antibiotics against pathogenic microbes. The substantial antibiofilm efficiency of biosynthesized Ag-NPs would also be helpful against sensitive and multidrug-resistant strains.

Keywords

Silver nanoparticle / Synergistic antibacterial activity / Antibiofilm activity / Aspergillus flavus / Emericella nidulans

References

[1] Bhainsa KC, D’Souza SK. Extracellular biosynthesis of silver nanoparticles using the fungus Aspergillus fumigatus. Colloids Surf B, 2006, 47: 160-164.

[2] Bihari P, Vippola M, Schultes S, Praetner M, Khandoga A, Reichel C, Coester C, Tuomi T, Rehberg M, Krombach F. Optimized dispersion of nanoparticles for biological in vitro and in vivo studies. Part Fiber Toxicol, 2008, 5: 1-14.

[3] Birla SS, Tiwari VV, Gade AK, Ingle AP, Yadav AP, Rai MK. Fabrication of silver nanoparticles by Phoma glomerata and its combined effect against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. Lett Appl Microbiol, 2009, 48: 173-179.

[4] Botelho MG. Fractional inhibitory concentration index of combinations of antibacterial agents against cariogenic organisms. J Dent, 2000, 28: 565-570.

[5] Chatterjee AK, Sarkar RK, Chattopadhyay AP, Aich P, Chakraborty R, Basu T. A simple robust method for synthesis of metallic copper nanoparticles of high antibacterial potency against E. coli. Nanotechnology, 2012, 23: 085103.

[6] Chaturvedi V, Verma P. Fabrication of silver nanoparticles from leaf extract of Butea monosperma (flame of forest) and their inhibitory effect on bloom-forming cyanobacteria. Bioresour Bioprocess, 2015, 2: 18.

[7] Chudasama B, Vala AK, Andhariya N, Mehta RV, Upadhyay RV. Highly bacterial resistant silver nanoparticles: synthesis and antibacterial activities. J Nanopart Res, 2010, 12: 1677-1685.

[8] Durán N, Marcato PD, Durán M, Yadav A, Gade A, Rai M. Mechanistic aspects in the biogenic synthesis of extracellular metal nanoparticles by peptides, bacteria, fungi, and plants. Appl Microbiol Biotechnol, 2011, 90: 1609-1624.

[9] Fayaz AM, Balaji K, Girilal M, Yadav R, Kalaichelvan PT, Venketesan R. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria. J Nanomed Nanotechnol, 2010, 6: 103-109.

[10] Fazay AM, Girilal M, Rahman M, Venkatesan R, Kalaichelvan PT. Biosynthesis of silver and gold nanoparticle using thermophilic bacterium Geobacillus stearothermophilus. Process Biochem, 2011, 46: 1958-1962.

[11] Goswami SR, Sahareen T, Singh M, Kumar S. Role of biogenic silver nanoparticles in disruption of cell-cell adhesion in Staphylococcus aureus and Escherichia coli biofilm. J Ind Eng Chem, 2015, 26: 73-80.

[12] Hwang I, Hwang JH, Choi H, Kim K, Lee DG. Synergistic effects between silver nanoparticles and antibiotics and the mechanisms involved. J Med Microbiol, 2012, 61: 1719-1726.

[13] Ingle A, Rai M, Gade A, Bawaskar MJ. Fusarium solani: a novel biological agent for the extracellular synthesis of silver nanoparticles. J Nanopart Res, 2009, 11: 2079-2085.

[14] Isenberg HD (2007) Synergism testing: broth microdilution checkerboard and broth macrodilution methods: In: Garcia LS (ed) Clinical microbiology procedures handbook, vol 2E. Microbiology ASM, p 5.12.1

[15] Jaidev LR, Narasimha G. Fungal mediated biosynthesis of silver nanoparticles, characterization and antimicrobial activity. Colloids Surf B, 2010, 81: 430-433.

[16] Jain N, Bhargava A, Majumdar S, Tarafdar JC, Panwar J. Extracellular biosynthesis and characterization of silver nanoparticles using Aspergillus flavus NJP08: a mechanism perspective. Nanoscale, 2011, 3: 635-641.

[17] Joo HS, Otto M. Molecular basis of in vivo biofilm formation by bacterial pathogens. Chem Biol, 2012, 19: 1503-1513.

[18] Jung WK, Koo HC, Kim KW, Shin S, Kim SH, Park YH. Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl Environ Microbiol, 2008, 74: 2171-2178.

[19] Kalishwaralal K, Kanth SBM, Pandian SRK, Deepak V, Gurunathan S. Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids Surf B, 2010, 79: 340-344.

[20] Keat CL, Aziz A, Eid AM, Elmarzugi NA. Biosynthesis of nanoparticles and silver nanoparticles. Bioresour Bioprocess, 2015, 2: 47.

[21] Khatami M, Pourseyedi S, Khatami M, Hamidi H, Zaeifi M, Soltani L. Synthesis of silver nanoparticles using seed exudates of Sinapis arvensis as a novel bioresource, and evaluation of their antifungal activity. Bioresour Bioprocess, 2015, 2: 19.

[22] Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, Kim SH, Park YK, Park YH, Hwang CY, Kim YK, Lee YS, Jeong DH, Cho MH. Antimicrobial effects of silver nanoparticles. Nanomed Nanotechnol Bio Med, 2007, 3: 95-101.

[23] Kora AJ, Arunachalam J. Assessment of antibacterial activity of silver nanoparticles on Pseudomonas aeruginosa and its mechanism of action. World J Microbiol Biotechnol, 2011, 27: 1209-1216.

[24] Li WR, Xie XB, Shi QS, Duan SS, Ouyang YS, Chen YB. Antibacterial effect of silver nanoparticles on Staphylococcus aureus. Biometals, 2011, 24: 135-141.

[25] Li G, He D, Qian Y, Guan B, Gao S, Cui Y, Yokoyama K, Wang L. Fungus-mediated green synthesis of silver nanoparticles using Aspergillus terreus. Int J Mol Sci, 2012, 13: 466-476.

[26] Marambio-Jones C, Hoek EMV. A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J Nanopart Res, 2010, 12: 1531-1551.

[27] McShan D, Ray PC, Yu H. Molecular toxicity mechanism of nanosilver. J Food Drug Anal, 2014, 22: 116-127.

[28] Nath D, Banerjee P. Green nanotechnology—a new hope for medical biology. Environ Toxicol Pharmacol, 2013, 36: 997-1014.

[29] Noguez C. Surface plasmons on metal nanoparticles: the influence of shape and physical environment. J Phys Chem C, 2007, 111: 3806-3819.

[30] Pal S, Tak YK, Song JM. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? a study of the gram-negative bacterium Escherichia coli. Appl Environ Microbiol, 2007, 73: 1712-1720.

[31] Park H, Park S, Roh J, Kim S, Choi K, Yi J, Kim Y, Yoon J. Removal characteristics of engineered nanoparticles by activated sludge. J Ind Eng Chem, 2013, 19: 614-619.

[32] Pelletier DA, Suresh AK, Holton GA, McKeown CK, Wang W, Gu B, Mortensen NP, Allison DP, Joy DC, Allison MR, Brown SD, Phelps TJ, Doktycz MJ. Effects of engineered cerium oxide nanoparticles on bacterial growth and viability. Appl Environ Microbiol, 2010, 76: 7981-7989.

[33] Quester K, Avalos-Borja M, Castro-Longoria E. Biosynthesis and microscopic study of metallic nanoparticles. Micron, 2013, 54–55: 1-27.

[34] Ramaswamy RK, Krishnamurthy PP, Kaliannan T. Mycogenic synthesis of silver nanoparticles by the Japanese environmental isolate Aspergillus tamarii. J Nanopart Res, 2012, 14: 860-862.

[35] Roy N, Gaur A, Jain A, Bhattacharya S, Rani V. Green synthesis of silver nanoparticles: an approach to overcome toxicity. Environ Toxicol Pharmacol, 2013, 36: 807-812.

[36] Saravanan M, Nanda A. Extracellular synthesis of silver bionanoparticles from Aspergillus clavatus and its antimicrobial activity against MRSA and MRSE. Colloids Surf B, 2010, 77: 214-218.

[37] Sintubin L, Verstraete W, Boon N. Biologically produced nanosilver: current state and future perspectives. Biotechnol Bioeng, 2012, 109: 2422-2436.

[38] Thirunavoukkarasu M, Balaji U, Behera S, Panda PK, Mishra BK. Biosynthesis of silver nanoparticle from leaf extract of Desmodium gangeticum (L.) DC. and its biomedical potential. Spectrochim Acta Part A, 2013, 116: 424-427.

[39] Vigneshwaran N, Ashtaputre NM, Varadarajan PV, Nachane RP, Paralikar KM, Balasubramanya RH. Biological synthesis of silver nanoparticles using the fungus Aspergillus flavus. Mater Lett, 2007, 61: 1413-1418.

[40] Yoon K, Byeon JH, Park J, Hwang J. Susceptibility constants of Escherichia coli and Bacillus subtilis to silver and copper nanoparticles. Sci Total Environ, 2007, 373: 572-575.

[41] Zhao K, Zhao J, Wu C, Zhang S, Deng Z, Hu X, Chen M, Peng B. Fabrication of silver-decorated sulfonated polystyrene microspheres for surface-enhanced Raman scattering and antibacterial applications. RSC Adv, 2015, 5: 69543-69554.

Funding

University Grants Commission (IN)(F.41-543/2012 (SR))